These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75. Atrial natriuretic peptide: a magic bullet for cancer therapy targeting Wnt signaling and cellular pH regulators. Serafino A; Pierimarchi P Curr Med Chem; 2014; 21(21):2401-9. PubMed ID: 24524761 [TBL] [Abstract][Full Text] [Related]
76. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Koller KJ; Lowe DG; Bennett GL; Minamino N; Kangawa K; Matsuo H; Goeddel DV Science; 1991 Apr; 252(5002):120-3. PubMed ID: 1672777 [TBL] [Abstract][Full Text] [Related]
77. Atrial natriuretic peptide (ANP) inhibits its own secretion via ANP(A) receptors: altered effect in experimental hypertension. Leskinen H; Vuolteenaho O; Toth M; Ruskoaho H Endocrinology; 1997 May; 138(5):1893-902. PubMed ID: 9112384 [TBL] [Abstract][Full Text] [Related]
78. B-type natriuretic peptide (BNP), not ANP, is the principal cardiac natriuretic peptide in vertebrates as revealed by comparative studies. Takei Y; Inoue K; Trajanovska S; Donald JA Gen Comp Endocrinol; 2011 May; 171(3):258-66. PubMed ID: 21362425 [TBL] [Abstract][Full Text] [Related]